Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS trial: oral clarithromycin added to β-lactam therapy in community-acquired pneumonia
2020-004452-15Phase 2Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of clarithromycin in community-acquired pneumonia (CAP) and pneumonia (2 arms), sponsored by Hellenic Institute for the Study of Sepsis. Primary endpoint: Primary composite endpoint at day 4. Started Nov 2020; status: completed.
02
Drugs
clarithromycin
03
Conditions
community-acquired pneumonia (CAP)pneumonia
Beyond the preview
Go deeper on 2020-004452-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004452-15.